VYCOThe NovaVision Solution NovaVision, a wholly-o

VYCOThe NovaVision Solution
NovaVision, a wholly-owned subsidiary of Vycor Medical, provides the first real hope for those who suffer
partial "permanent" blindness due to stroke or TBI - these individuals constitute approximately 16% of all stroke
and TBI victims. This hope comes in the form of a computer-based "vision restoration therapy" product (VRT).
NovaVision’s VRT is an FDA-cleared medical device and both its VRT and NeET products have CE clearance
for rehabilitation of vision-field loss resulting from neurological damage. The Company's VRT product is a
patient-specific diagnostic and therapeutic platform with extensive clinical data supporting its ability to increase
a patient’s visual field; more than 2,000 patients have been treated with VRT as of today. Use of recentlyacquired
SightScience's NeET has also been shown to increase visual sensitivity within the blind field in clinical
studies and is marketed in the EU. Note that all other vision therapies available today focus on vision-loss
compensation and substitution such as prisms, making NovaVision's products the only commercially-viable,
clinically-supported alternative that actual restores some degree of "permanently" lost sight. In our view this
constitutes a legitimate medical break-through that should eventually improve the lives of millions.
NovaVision's VRT product uses computer-generated light patterns to stimulate nerves in or near the brain's
optical centers, where light is processed and interpreted. Over fifteen years of clinical research, it has been
shown that in approximately 70% of cases patients using NovaVision's VRT system over a three to six
month period experience significant recovery in at least one functional outcome. In many cases this
recovery is enough to restore lost abilities such as reading, avoiding unseen objects while walking, or in some
cases even driving a car. Although this therapy addresses only 16% of stroke and TBI cases, this still represents
a huge market for Company of this size. As the Company's VRT system becomes widely adopted by
physicians, rehabilitation centers, physician centers, and by the patients they treat, it should permanently change
. http://www.novavision.com